Clinical impact of concurrent autologous adoptive T cells immunotherapy in active COVID-19 infected cancer patients for chemotherapy

Related articles

1. Immunogenicity and vaccine effectiveness of COVID-19 vaccines in people on immunosuppressive therapies

   This article has 13 authors:

   1. Eva Stadler
   2. Shanchita R Khan
   3. Karen M Elias
   4. Ece Egilmezer
   5. Chansavath Phetsouphanh
   6. Priyanka Hastak
   7. Rehana V Hewavisenti
   8. Ruchika V Joshi
   9. Tari Turner
   10. Deborah Cromer
   11. Sarah C Sasson
   12. Miles P Davenport
   13. David S Khoury

2. Cysteine supplementation reverses immune dysfunction in cancer patients with severe COVID-19

   This article has 24 authors:

   1. Tiffany Merlinsky
   2. Jahan Rahman
   3. William T. Johnson
   4. Lisa McGary
   5. Simon Grassmann
   6. Jennifer Zhang
   7. Abdulraouf Abdulraouf
   8. Hannah L. Kalvin
   9. Katherine Panageas
   10. Jasmine Nicodemus
   11. Elizabeth Cathcart
   12. Ya-Hui Lin
   13. Kinga K. Hosszu
   14. Mirela Berisa
   15. Olga Lyudovyk
   16. Gilles Salles
   17. Jaap J. Boelens
   18. N. Esther Babady
   19. Junyue Cao
   20. Jedd D. Wolchok
   21. Joseph C. Sun
   22. James Heath
   23. Benjamin Greenbaum
   24. Santosha Vardhana

3. Age and CMV are not associated with clinical or immunological response to immune checkpoint blockade

   This article has 8 authors:

   1. Jack M Edwards
   2. Sashendra Senthi
   3. Robin Smith
   4. Hayley Burridge
   5. Carole Owens
   6. Mark Shackleton
   7. Miles C Andrews
   8. Menno C. van Zelm